Speeches & presentations
Search through our archive of speeches and presentations from conferences and events.
Filter by
-
Barclays Global Healthcare Conference 2021
Deborah Waterhouse, CEO of ViiV Healthcare, participated in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10 at 8:35am ET/1:35pm GMT, during which she provided an update on the progress GSK is making in the HIV space.
-
Cowen 41st Annual Health Care Conference
Hal Barron, Chief Scientific Officer and President R&D, participated in a fireside chat at the Cowen 41st Annual Health Care Conference on Monday, March 1 2021 at 5:20pm GMT /12:20pm ET, during which he discussed updates on the progress GSK is making in R&D.
-
Guggenheim Healthcare Talks 2021
Axel Hoos, GSK Senior Vice-President Oncology R&D, joined a Fireside Chat with Seamus Fernandez at the Guggenheim Healthcare Talks 2021 Oncology Days, Thursday, February 11, at 10AM ET, where the duo discussed GSK Oncology R&D progress.
-
39th annual JP Morgan Virtual Healthcare Conference
Hal Barron, Chief Scientific Officer and President R&D, presented at the 39th annual JP Morgan Virtual Healthcare Conference on Tuesday 12 January at 10:50-11:30am ET / 15:50-16:30 GMT. The presentation was followed by a Q&A session.
The audio-only direct link for our virtual session at the 39th Annual JP Morgan Healthcare Conference is now available. Please use the below link to access.
-
Goldman Sachs 13th Annual Healthcare Unscripted CEOs Conference
Emma Walmsley, CEO, hosted a fireside chat at the Goldman Sachs 13th annual healthcare unscripted CEOs conference on Tuesday 5 January at 12:00 GMT.
-
Morgan Stanley ESG Insights Conference
Phil Thomson, President Global Affairs, will host a fireside chat at the Morgan Stanley ESG Insights Conference, taking place Wednesday, 9 December 2020 at 15:25 GMT / 10:25am EST.
-
Evercore ISI HealthCONx Conference
Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at Evercore ISI HealthCONx Conference on Tuesday, 1 December 2020 at 13:00 GMT / 8:00am EST, during which provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.
-
Investor and analyst call to discuss RSV vaccines data
GSK will hold an investor and analyst call hosted by Hal Barron, Chief Scientific Officer and President R&D, Roger Connor, President, GSK Vaccines, and Emmanuel Hanon, SVP and Head of Vaccines R&D, to discuss data on two respiratory syncytial virus (RSV) vaccine candidates to be presented at ID Week.
This event will take place on Thursday 22 October at 3:30pm CET / 2:30pm BST / 9:30am EDT.
-
BofA Global Healthcare Conference
Emma Walmsley, CEO, hosted a fireside chat at the BofA Global Healthcare Conference on Thursday 17 September at 0815 BST.
-
Citi 15th Annual Biopharma Conference
Hal Barron, Chief Scientific Officer and President R&D, will host a fireside chat at the Citi 15th Annual Biopharma Conference taking place Wednesday 9 September 2020 at 16:40 BST/11:40am EDT, during which he will provide an update on the progress GSK is making in the R&D pipeline.
-
Investor and analyst call to discuss HIV Prevention Treatment Network 083 study
GSK will hold an investor/analyst call hosted by David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO, ViiV Healthcare and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare to discuss the final efficacy analysis from the global HIV Prevention Treatment Network (HPTN) 083 study evaluating investigational long-acting cabotegravir for HIV prevention.
This event will take place on: Thursday 9th July at 14:00 BST / 09:00 EDT
-
Guggenheim Healthcare Talks Idea Forum, New York City
Axel Hoos, Senior Vice-President Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum, Oncology Day, held in New York City on Thursday, February 13th, during which he provided an update on GSK Oncology R&D progress.
-
38th annual JP Morgan Healthcare Conference, San Francisco
Emma Walmsley, CEO, presented at the 38th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 14 January, and provided an overview of GSK’s priorities and the progress the company made during 2019. The presentation was followed by a Q&A session.
-
Investor and Analyst call from DREAMM-2 data
On Tuesday, 17 December 2019 at 17:00 GMT / 12:00 EST, Hal Barron, Chief Scientific Officer and President of R&D, Luke Miels, President Pharmaceuticals and Axel Hoos, SVP Oncology R&D will host an investor/analyst conference call to discuss GSK’s pivotal DREAMM-2 data on belantamab mafodotin (GSK’916).
-
Investor and Analyst call from ESMO 2019
On Monday, 30 September 2019, Dr Hal Barron, Chief Scientific Officer and President R&D and Luke Miels, President, GSK Global Pharmaceuticals will host an investor conference call following the presentation of the PRIMA data on Zejula (niraparib) and the INDUCE-1 data on GSK’609 (ICOS) at the 2019 European Society for Medical Oncology (ESMO) congress. The call will also feature participation from an external expert in ovarian cancer and other GSK senior oncology leaders.
-
GSK Vaccines Investor Event
Roger Connor, President, GSK Vaccines, hosted an educational session on GSK’s Vaccines business at our manufacturing site in Wavre, Belgium on Thursday 26 September at 13:30 CET / 12:30 BST / 7:30 EDT.
-
Goldman Sachs’ 40th Annual Global Healthcare Conference, California
Hal Barron, Chief Scientific Officer and President R&D, hosted a fireside chat at Goldman Sachs’ 40th Annual Global Healthcare Conference, which took place in Rancho Palos Verdes, California on Wednesday 12 June, during which he has provided an update on the progress being made in GSK’s R&D organisation.
-
Jefferies 2019 Healthcare Conference, New York
David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, and Deborah Waterhouse, CEO of ViiV Healthcare, hosted a fireside chat at the Jefferies 2019 Healthcare Conference in New York on Thursday 6 June, during which they provided an update on the progress GSK and ViiV Healthcare have made this year.
-
Bernstein Consumer Healthcare & Nutrition Seminar, London
Tobias Hestler, CFO GSK Consumer Healthcare, hosted a fireside chat at the Bernstein Consumer Healthcare & Nutrition Seminar in London on Tuesday 4 June during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.
